{"organizations": [], "uuid": "a60961bfd5a67c18f6bd79bd481db428d2e6574c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180117.html", "section_title": "Archive News &amp; Video for Wednesday, 17 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-amgen-says-analysis-from-kyprolis/brief-amgen-says-analysis-from-kyprolis-trial-published-in-journal-of-clinical-oncology-idUSASB0C1B2", "country": "US", "domain_rank": 408, "title": "BRIEF-Amgen says Analysis From Kyprolis Trial Published in Journal Of Clinical Oncology", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.343, "site_type": "news", "published": "2018-01-18T05:30:00.000+02:00", "replies_count": 0, "uuid": "a60961bfd5a67c18f6bd79bd481db428d2e6574c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-amgen-says-analysis-from-kyprolis/brief-amgen-says-analysis-from-kyprolis-trial-published-in-journal-of-clinical-oncology-idUSASB0C1B2", "ord_in_thread": 0, "title": "BRIEF-Amgen says Analysis From Kyprolis Trial Published in Journal Of Clinical Oncology", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "amgen inc", "sentiment": "negative"}, {"name": "brief-amgen", "sentiment": "negative"}, {"name": "aspir", "sentiment": "negative"}, {"name": "analysis from kyprolis trial published", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 17 (Reuters) - Amgen Inc:\n* OVERALL SURVIVAL ANALYSIS FROM KYPROLISÂ® (CARFILZOMIB) PHASE 3 ASPIRE TRIAL PUBLISHED IN THE JOURNAL OF CLINICAL ONCOLOGY Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-18T05:30:00.000+02:00", "crawled": "2018-01-18T16:03:23.000+02:00", "highlightTitle": ""}